1. Home
  2. CDTX vs RHI Comparison

CDTX vs RHI Comparison

Compare CDTX & RHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDTX
  • RHI
  • Stock Information
  • Founded
  • CDTX 2012
  • RHI 1948
  • Country
  • CDTX United States
  • RHI United States
  • Employees
  • CDTX N/A
  • RHI N/A
  • Industry
  • CDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • RHI Professional Services
  • Sector
  • CDTX Health Care
  • RHI Consumer Discretionary
  • Exchange
  • CDTX Nasdaq
  • RHI Nasdaq
  • Market Cap
  • CDTX 2.8B
  • RHI 3.3B
  • IPO Year
  • CDTX 2015
  • RHI N/A
  • Fundamental
  • Price
  • CDTX $219.75
  • RHI $25.82
  • Analyst Decision
  • CDTX Buy
  • RHI Sell
  • Analyst Count
  • CDTX 13
  • RHI 7
  • Target Price
  • CDTX $119.44
  • RHI $40.00
  • AVG Volume (30 Days)
  • CDTX 2.2M
  • RHI 2.9M
  • Earning Date
  • CDTX 11-06-2025
  • RHI 10-22-2025
  • Dividend Yield
  • CDTX N/A
  • RHI 9.16%
  • EPS Growth
  • CDTX N/A
  • RHI N/A
  • EPS
  • CDTX N/A
  • RHI 1.54
  • Revenue
  • CDTX N/A
  • RHI $5,458,499,000.00
  • Revenue This Year
  • CDTX N/A
  • RHI N/A
  • Revenue Next Year
  • CDTX N/A
  • RHI $0.90
  • P/E Ratio
  • CDTX N/A
  • RHI $16.71
  • Revenue Growth
  • CDTX N/A
  • RHI N/A
  • 52 Week Low
  • CDTX $15.02
  • RHI $25.22
  • 52 Week High
  • CDTX $220.32
  • RHI $78.41
  • Technical
  • Relative Strength Index (RSI)
  • CDTX 89.35
  • RHI 32.07
  • Support Level
  • CDTX $102.46
  • RHI $25.38
  • Resistance Level
  • CDTX $218.85
  • RHI $26.63
  • Average True Range (ATR)
  • CDTX 4.30
  • RHI 1.08
  • MACD
  • CDTX 12.80
  • RHI 0.18
  • Stochastic Oscillator
  • CDTX 99.47
  • RHI 16.86

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

About RHI Robert Half Inc.

Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.

Share on Social Networks: